Table 1 COVID-19 vaccines under study
Trade name | International nonproprietary name | Trial name | Manufacturer | Vaccine type | Available in Finland |
|---|---|---|---|---|---|
Comirnaty | Tozinameran | BNT162b2 | BioNTech/Pfizer | mRNA vaccine | Since December 27, 2020 |
Spikevax | Elasomeran | mRNA-1273 | Moderna | mRNA vaccine | Since January 20, 2021 |
Vaxzevria | ChAdOx1-S [recombinant] | AZD1222 | Oxford/AstraZeneca | Adenovirus vector vaccine | From February 10 to November 30, 2021 |